Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.88
Profound Medical Corp. entered into Placement Agent Agreement with Konik Capital Partners, LLC, a division of T.R. Winston and Company, LLC valued at cash fee of 5.0% of gross proceeds from the sale of Shares plus reimbursement of documented out-of-p (effective 2025-12-19).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Konik Capital Partners, LLC, a division of T.R. Winston and Company, LLC
- Value
- cash fee of 5.0% of gross proceeds from the sale of Shares plus reimbursement of documented out-of-p
- Effective
- 2025-12-19
Exact text from the filing
On December 19, 2025, the Company entered into a placement agency agreement (the “Placement Agent Agreement”) with Konik Capital Partners, LLC, a division of T.R. Winston and Company, LLC (“Konik Capital Partners”) pursuant to which the Company engaged Konik Capital Partners as the placement agent (the “Placement Agent”) in connection with the Offering.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Profound Medical Corp. entered into Securities Purchase Agreement with certain investors (the Purchasers) valued at aggregate of 5,142,870 common shares at $7.00 per share for aggregate gross proceeds of $36 million (effective 2025-12-19).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain investors (the Purchasers)
- Value
- aggregate of 5,142,870 common shares at $7.00 per share for aggregate gross proceeds of $36 million
- Effective
- 2025-12-19
Exact text from the filing
On December 19, 2025, Profound Medical Corp. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain investors (collectively, the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a registered direct offering (the “Offering”) an aggregate of 5,142,870 shares (the “Shares”) of the Company’s common shares (the “Common Shares”), at a price of $7.00 per share, for aggregate gross proceeds to the Company of $36 million before deducting the placement agent’s fees and related offering expenses.
View on SEC.gov